Inhibition of urokinase plasminogen activator expression by deferoxamine in cultured human prostate cancer cells

被引：0
|
作者：
Ornstein, DL
Zacharki, LR
机构：
[1] VET ADM MED CTR, WHITE RIVER JCT, VT USA
[2] DARTMOUTH HITCHCOCK MED CTR, LEBANON, NH 03766 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P2263 / P2263
页数：1
相关论文
共 50 条
  • [31] TISSUE PLASMINOGEN ACTIVATOR AND UROKINASE PLASMINOGEN ACTIVATOR IN HUMAN EPILEPTOGENIC PATHOLOGIES
    Iyer, A. M.
    Zurolo, E.
    Boer, K.
    Baayen, J. C.
    Giangaspero, F.
    Arcella, A.
    Di Gennaro, G. C.
    Esposito, V.
    Spliet, W. G. M.
    Van Rijen, P. C.
    Troost, D.
    Gorter, J. A.
    Aronica, E.
    NEUROSCIENCE, 2010, 167 (03) : 929 - 945
  • [32] Hypomethylation of the urokinase plasminogen activator promoter CpG island promotes its aberrant expression in prostate cancer
    Pulukuri, Sai Murali
    Rao, Jasti S.
    CANCER RESEARCH, 2006, 66 (08)
  • [33] Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells
    Iguchi, Kazuhiro
    Tatsuda, Yoshiki
    Usui, Shigeyuki
    Hirano, Kazuyuki
    ANTICANCER RESEARCH, 2007, 27 (6B) : 3843 - 3848
  • [34] Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator
    Bin Hafeez, Bilal
    Adhami, Vaqar Mustafa
    Asim, Mohammad
    Siddiqui, Imtiaz A.
    Bhat, Kumar M.
    Zhong, Weixiong
    Saleem, Mohammad
    Din, Maria
    Setaluri, Vijayasaradhi
    Mukhtar, Hasan
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 452 - 459
  • [35] Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor
    Kobayashi, H
    Suzuki, M
    Sun, GW
    Hirashima, Y
    Terao, T
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1481 (02): : 310 - 316
  • [36] Evidence for the expression of urokinase-type plasminogen activator by human venous endothelial cells in vivo
    Camoin, L
    Pannell, R
    Anfosso, F
    Lefevre, JP
    Sampol, J
    Gurewich, V
    Dignat-George, F
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 961 - 967
  • [37] Expression and significance of urokinase-type plasminogen activator in human gliomas
    章翔
    步星耀
    甄海宁
    费舟
    吴景文
    顾建文
    易声禹
    王占祥
    Chinese Medical Journal, 2000, (09)
  • [38] Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells
    V Pavet
    Y Shlyakhtina
    T He
    D G Ceschin
    P Kohonen
    M Perälä
    O Kallioniemi
    H Gronemeyer
    Cell Death & Disease, 2014, 5 : e1043 - e1043
  • [39] Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
    Tae-Dong Kim
    Kyoung-Sub Song
    Ge Li
    Hoon Choi
    Hae-Duck Park
    Kyu Lim
    Byung-Doo Hwang
    Wan-Hee Yoon
    BMC Cancer, 6
  • [40] Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis
    Katie Forbes
    Karin Gillette
    Laura A. Kelley
    Inder Sehgal
    World Journal of Urology, 2004, 22 : 67 - 71
12345